LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.01 | 27.76 | 252 | 7000 | 0.0360 | 0.3185 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.01 | 27.76 | 1643 | 7000 | 0.2347 | 0.6678 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 83.72 | 27.76 | 1182 | 7055 | 0.1675 | 0.5993 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 83.72 | 27.76 | 1188 | 7055 | 0.1684 | 0.6003 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 83.72 | 27.76 | 265 | 7055 | 0.0376 | 0.3263 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 83.72 | 27.76 | 1671 | 7055 | 0.2368 | 0.6701 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 85.42 | 27.76 | 1197 | 7025 | 0.1704 | 0.6024 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 85.42 | 27.76 | 1207 | 7025 | 0.1718 | 0.6040 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 85.42 | 27.76 | 261 | 7025 | 0.0372 | 0.3241 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 85.42 | 27.76 | 1650 | 7025 | 0.2349 | 0.6681 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.13 | 27.76 | 1201 | 6987 | 0.1719 | 0.6038 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.13 | 27.76 | 1210 | 6987 | 0.1732 | 0.6053 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.13 | 27.76 | 238 | 6987 | 0.0341 | 0.3092 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.13 | 27.76 | 1710 | 6987 | 0.2447 | 0.6764 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 88.84 | 27.76 | 1200 | 6965 | 0.1723 | 0.6040 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 88.84 | 27.76 | 1207 | 6965 | 0.1733 | 0.6052 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 88.84 | 27.76 | 251 | 6965 | 0.0360 | 0.3182 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 88.84 | 27.76 | 1715 | 6965 | 0.2462 | 0.6775 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 90.55 | 27.76 | 1232 | 6928 | 0.1778 | 0.6101 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 90.55 | 27.76 | 1243 | 6928 | 0.1794 | 0.6119 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 90.55 | 27.76 | 249 | 6928 | 0.0359 | 0.3172 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 90.55 | 27.76 | 1703 | 6928 | 0.2458 | 0.6769 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.25 | 27.76 | 1237 | 6873 | 0.1800 | 0.6120 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.25 | 27.76 | 1248 | 6873 | 0.1816 | 0.6138 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.25 | 27.76 | 258 | 6873 | 0.0375 | 0.3236 | MN20160318_Q01 | L22 |